MFB · NZX

My Food Bag Group (MFB)

Name: My Food Bag Group (MFB) financial result history
Creator: Annolyse

Consumer / Meal kitsCovered: FY22 - FY269 published briefings

My Food Bag Group is an NZX-listed consumer / meal kits company. Its latest covered result is FY26, with FY22 - FY26 of source-backed result history on Annolyse.

Sections

Latest metrics

FY26, released 21 May 2026

← Swipe to view more

MFB latest metrics
Metric	Value	Change
Revenue	$170.2m	↑ +5.0%
EBITDA	$16.4m	↑ +1.9%
NPAT	$6.7m	↑ +4.7%
Operating cash flow	$13.5m	↑ +2.3%
OCF / EBITDA %	82.5%	↑ +0.3pp
Net debt	$1.9m	↓ -72.9%
Net debt / EBITDA	0.11x	↓ -74.4%
ROE %	9.2%Outside range low roe. 9.2%; 4-period range 9.3% to 29.9%. ROE: 9.2%, below normal range; 4-period mean 16.4%, range 9.3%-29.9%.	↓ -0.0pp
DPS	0.4c	↓ -47.4%
Payout ratio vs NPAT %	63.3%	↑ +13.3pp

Source: latest published briefing (FY26, released 21 May 2026). Change compares against the prior equivalent period: FY25, released 22 May 2025.

Valuation

Trailing P/E, EV/EBITDA, price-to-book and price-to-free-cash-flow ratios combine the latest available close with filing data. They are comparative measures, not forecasts or recommendations.

Prices as at close, 18 September 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$72.5m

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

10.83x

Recent market cap compared with trailing earnings.

EPS

0.03

Recent filing-derived earnings per share.

PEG

2.3x

P/E compared with recent earnings growth.

EV/EBITDA

4.54x

Enterprise value compared with recent EBITDA.

P/FCF

8.53x

Market cap compared with recent free cash flow.

P/B

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

6.7%

Trailing dividends compared with the latest close.

Total return

Not available

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch values for each observation. Expand the chart to see more detail.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

Loading chart...

P/E over time

Filing-period markers only: EOD close on or before each release date divided by filing-derived trailing NPAT where both inputs verify.

Loading chart...

Chat

Ask about MFB

Ask follow-up questions about My Food Bag Group's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about MFB

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Financial history

Performance over time

The latest period is shown first.

← Swipe to view more

MFB metric history
Metric	FY2612 MONTHS21 May 2026	HY266 MONTHS20 November 2025	FY2512 MONTHS22 May 2025	HY256 MONTHS21 November 2024	FY2412 MONTHS23 November 2023	HY246 MONTHS23 November 2023	FY2312 MONTHS19 May 2023	HY236 MONTHS18 November 2022	FY2212 MONTHS20 May 2022	Trend
Revenue	$170.2m	$85.4m	$162.1m	$82.2m	$175.7m	$83.8m	$175.7m	$94.4m	$194m	Chart
Revenue growth %	5.0%Outside range high revenue growth. 5%; 4-period range -9.4% to 1.7%. Revenue growth: 5.0%, above normal range; 4-period mean -2.0%, range -9.4%-1.7%.	3.8%Outside range high revenue growth. 3.8%; 3-period range -11.2% to -1.9%. Revenue growth: 3.8%, above normal range; 3-period mean -5.7%, range -11.2%--1.9%.	-0.1%	-1.9%	0.0%	-11.2%Outside range low revenue growth. -11.2%; 3-period range -4.1% to 3.8%. Revenue growth: -11.2%, below normal range; 3-period mean -0.7%, range -4.1%-3.8%.	-9.4%Unprecedented low revenue growth. -9.4%; 4-period range -0.1% to 5%. Revenue growth: -9.4%, unprecedented low; 4-period mean 1.7%, range -0.1%-5.0%.	-4.1%	1.7%	Chart HY26 Revenue growth %: Outside range high revenue growth. 3.8%; 3-period range -11.2% to -1.9%. Revenue growth: 3.8%, above normal range; 3-period mean -5.7%, range -11.2%--1.9%. FY26 Revenue growth %: Outside range high revenue growth. 5%; 4-period range -9.4% to 1.7%. Revenue growth: 5.0%, above normal range; 4-period mean -2.0%, range -9.4%-1.7%.
EBITDA	$16.4m	$7.2m	$16.1m	$7.8m	—	$7.4m	$18.2m	$11.5m	$34.2m	Chart
EBITDA margin %	9.6%Outside range low ebitda margin. 9.6%; 3-period range 9.9% to 17.6%. EBITDA margin: 9.6%, below normal range; 3-period mean 12.6%, range 9.9%-17.6%.	8.4%Outside range low ebitda margin. 8.4%; 3-period range 8.8% to 12.2%. EBITDA margin: 8.4%, below normal range; 3-period mean 10.2%, range 8.8%-12.2%.	9.9%	9.5%	—	8.8%	10.4%	12.2%Outside range high ebitda margin. 12.2%; 3-period range 8.4% to 9.5%. EBITDA margin: 12.2%, above normal range; 3-period mean 8.9%, range 8.4%-9.5%.	17.6%Outside range high ebitda margin. 17.6%; 3-period range 9.6% to 10.4%. EBITDA margin: 17.6%, above normal range; 3-period mean 10.0%, range 9.6%-10.4%.	Chart HY26 EBITDA margin %: Outside range low ebitda margin. 8.4%; 3-period range 8.8% to 12.2%. EBITDA margin: 8.4%, below normal range; 3-period mean 10.2%, range 8.8%-12.2%. FY26 EBITDA margin %: Outside range low ebitda margin. 9.6%; 3-period range 9.9% to 17.6%. EBITDA margin: 9.6%, below normal range; 3-period mean 12.6%, range 9.9%-17.6%.
PBT	$9m	$3.6m	$8.6m	$4.1m	$3.5m	$3.5m	$11m	$8.2m	$27.8m	Chart
PBT growth %	4.7%	-12.2%	0.0%	17.1%Outside range high pbt growth. 17.1%; 3-period range -57.3% to -12.2%. PBT growth: 17.1%, above normal range; 3-period mean -35.1%, range -57.3%--12.2%.	-68.2%Outside range low pbt growth. -68.2%; 4-period range -60.4% to 208.9%. PBT growth: -68.2%, below normal range; 4-period mean 38.3%, range -60.4%-208.9%.	-57.3%Outside range low pbt growth. -57.3%; 3-period range -35.9% to 17.1%. PBT growth: -57.3%, below normal range; 3-period mean -10.3%, range -35.9%-17.1%.	-60.4%	-35.9%	208.9%Unprecedented high pbt growth. 208.9%; 4-period range -68.2% to 4.7%. PBT growth: 208.9%, unprecedented high; 4-period mean -31.0%, range -68.2%-4.7%.	Chart FY24 PBT growth %: Outside range low pbt growth. -68.2%; 4-period range -60.4% to 208.9%. PBT growth: -68.2%, below normal range; 4-period mean 38.3%, range -60.4%-208.9%. HY25 PBT growth %: Outside range high pbt growth. 17.1%; 3-period range -57.3% to -12.2%. PBT growth: 17.1%, above normal range; 3-period mean -35.1%, range -57.3%--12.2%.
NPAT	$6.7m	$2.9m	$6.4m	$3m	$7.9m	$2.5m	$7.9m	$5.9m	$20m	Chart
NPAT growth %	4.7%	-3.3%	6.7%	20.0%Outside range high npat growth. 20%; 3-period range -57.6% to -3.3%. NPAT growth: 20.0%, above normal range; 3-period mean -32.7%, range -57.6%--3.3%.	0.0%	-57.6%Outside range low npat growth. -57.6%; 3-period range -37.2% to 20%. NPAT growth: -57.6%, below normal range; 3-period mean -6.8%, range -37.2%-20.0%.	-60.5%Outside range low npat growth. -60.5%; 4-period range 0% to 733.3%. NPAT growth: -60.5%, below normal range; 4-period mean 186.2%, range 0.0%-733.3%.	-37.2%	733.3%Unprecedented high npat growth. 733.3%; 4-period range -60.5% to 6.7%. NPAT growth: 733.3%, unprecedented high; 4-period mean -12.3%, range -60.5%-6.7%.	Chart HY25 NPAT growth %: Outside range high npat growth. 20%; 3-period range -57.6% to -3.3%. NPAT growth: 20.0%, above normal range; 3-period mean -32.7%, range -57.6%--3.3%.
Operating cash flow	$13.5m	$5.8m	$13.2m	$6.3m	—	$4.9m	$9.8m	$5.5m	$29.5m	Chart
OCF / EBITDA %	82.5%	80.6%Outside range high ocf / ebitda cash conversion. 80.6%; 3-period range 47.7% to 80.3%. OCF / EBITDA cash conversion: 80.6%, above normal range; 3-period mean 64.9%, range 47.7%-80.3%.	82.2%	80.3%	—	66.6%	53.6%Outside range low ocf / ebitda cash conversion. 53.6%; 3-period range 82.2% to 86.3%. OCF / EBITDA cash conversion: 53.6%, below normal range; 3-period mean 83.7%, range 82.2%-86.3%.	47.7%Outside range low ocf / ebitda cash conversion. 47.7%; 3-period range 66.6% to 80.6%. OCF / EBITDA cash conversion: 47.7%, below normal range; 3-period mean 75.8%, range 66.6%-80.6%.	86.4%Outside range high ocf / ebitda cash conversion. 86.3%; 3-period range 53.6% to 82.5%. OCF / EBITDA cash conversion: 86.3%, above normal range; 3-period mean 72.8%, range 53.6%-82.5%.	Chart HY26 OCF / EBITDA %: Outside range high ocf / ebitda cash conversion. 80.6%; 3-period range 47.7% to 80.3%. OCF / EBITDA cash conversion: 80.6%, above normal range; 3-period mean 64.9%, range 47.7%-80.3%.
FCF pre-lease	$8.5m	$3.1m	$10.1m	$6.1m	—	$3.6m	$2m	$2.7m	$24.1m	Chart
FCF post-lease	$8.5m	$3.1m	—	—	—	—	—	—	$24.1m	Chart
DPS	0.4c	0.8c	0.8c	0.7c	—	—	3.0c	3.0c	4.0c	Chart
Payout ratio vs NPAT %	63.3%	75.0%	50.0%	65.0%	—	—	—	150.0%	87.5%	Chart
Annual payout ratio vs EPS %	63.3%	—	50.0%	—	—	—	—	—	87.5%	Chart
ROE %	9.2%Outside range low roe. 9.2%; 4-period range 9.3% to 29.9%. ROE: 9.2%, below normal range; 4-period mean 16.4%, range 9.3%-29.9%.	4.1%	9.3%	4.5%	12.9%	4.0%	13.5%	9.3%	29.9%Unprecedented high roe. 29.9%; 4-period range 9.2% to 13.5%. ROE: 29.9%, unprecedented high; 4-period mean 11.2%, range 9.2%-13.5%.	Chart FY26 ROE %: Outside range low roe. 9.2%; 4-period range 9.3% to 29.9%. ROE: 9.2%, below normal range; 4-period mean 16.4%, range 9.3%-29.9%.
Net debt	$1.9m	$5.5m	$6.9m	$9.7m	—	$14.1m	$15.3m	$5.9m	-$2.5m	Chart
Net debt / EBITDA	0.11x	0.77x	0.43x	1.24x	—	1.91xOutside range high net debt / ebitda. 1.91x; 3-period range 0.51x to 1.2x. Net debt / EBITDA: 1.91x, above normal range; 3-period mean 0.83x, range 0.51x-1.20x.	0.84xOutside range high net debt / ebitda. 0.84x; 3-period range -0.1x to 0.43x. Net debt / EBITDA: 0.84x, above normal range; 3-period mean 0.15x, range -0.10x-0.43x.	0.51xOutside range low net debt / ebitda. 0.51x; 3-period range 0.77x to 1.91x. Net debt / EBITDA: 0.51x, below normal range; 3-period mean 1.29x, range 0.77x-1.91x.	n/m	Chart HY24 Net debt / EBITDA: Outside range high net debt / ebitda. 1.91x; 3-period range 0.51x to 1.2x. Net debt / EBITDA: 1.91x, above normal range; 3-period mean 0.83x, range 0.51x-1.20x.
Debtor days	3Unprecedented high debtor days. 3d; 4-period range 0d to 1d. Debtor days: 3.0 days, unprecedented high; 4-period mean 0.8 days, range 0.4 days-1.2 days.	10Outside range high debtor days. 10d; 3-period range 1d to 1d. Debtor days: 9.8 days, above normal range; 3-period mean 1.1 days, range 0.9 days-1.3 days.	1	1	1	1	1	1Outside range low debtor days. 1d; 3-period range 1d to 10d. Debtor days: 0.9 days, below normal range; 3-period mean 4.1 days, range 1.2 days-9.8 days.	0Outside range low debtor days. 0d; 4-period range 1d to 3d. Debtor days: 0.4 days, below normal range; 4-period mean 1.4 days, range 0.7 days-3.0 days.	Chart HY26 Debtor days: Outside range high debtor days. 10d; 3-period range 1d to 1d. Debtor days: 9.8 days, above normal range; 3-period mean 1.1 days, range 0.9 days-1.3 days. FY26 Debtor days: Unprecedented high debtor days. 3d; 4-period range 0d to 1d. Debtor days: 3.0 days, unprecedented high; 4-period mean 0.8 days, range 0.4 days-1.2 days.
Inventory days	2	3	1Unprecedented low inventory days. 1d; 4-period range 2d to 5d. Inventory days: 0.9 days, unprecedented low; 4-period mean 3.9 days, range 1.8 days-4.9 days.	1	5	4	4	5	5Outside range high inventory days. 5d; 4-period range 1d to 5d. Inventory days: 4.9 days, above normal range; 4-period mean 2.9 days, range 0.9 days-4.5 days.	Chart FY25 Inventory days: Unprecedented low inventory days. 1d; 4-period range 2d to 5d. Inventory days: 0.9 days, unprecedented low; 4-period mean 3.9 days, range 1.8 days-4.9 days.
Total assets	$106.8m	$105.5m	$103.5m	$105.5m	$107.6m	$107.6m	$108.6m	$106.5m	$105.7m	Chart

Reference: annolyse.ai/companies/mfb

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

Loading chart...

Revenue growth

Like-period revenue growth where comparable.

Loading chart...

EBITDA-equivalent

Company-specific earnings measure where disclosed.

Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

Loading chart...

NPAT

Statutory profit after tax.

Loading chart...

Operating cash flow

Cash generated from operations.

Loading chart...

More financial metrics

Additional filing-backed metrics for this company. Each point links to the relevant published briefing.

OCF / EBITDA

Cash conversion against earnings.

Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

Loading chart...

FCF post-lease

Free cash flow after lease payments where available.

Loading chart...

ROE

Return on equity.

Loading chart...

Net debt

Borrowings less cash; negative values indicate net cash.

Loading chart...

Net debt / EBITDA

Leverage ratio, suppressed where earnings are not meaningful.

Loading chart...

DPS

Dividend per share declared for the period.

Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

Loading chart...

Debtor days

Receivables days where the working-capital inputs are source-backed.

Loading chart...

Inventory days

Inventory days where the working-capital inputs are source-backed.

Loading chart...

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

Loading chart...

The setup & the reality

HY26 → FY26 Follow-through

The latest result is checked against what the prior briefing said to watch.

Historical setup

What HY26 said to watch

Previous analysisHY26Result released20 November 2025Annolyse analysis published22 April 2026

From Revenue grew 3.8% but a $4.4m working-capital build drained cash

HY25 was 50.7% of FY25 revenue, 48.4% of FY25 EBITDA and 46.5% of FY25 NPAT, so the pattern is mildly second-half weighted on earnings. Annualising HY26 revenue gives NZ$170.8m versus FY25 of NZ$162.1m, which would be a step up if the trajectory holds. No FY26 revenue, EBITDA or margin target was disclosed in this release, so the second-half judgement rests on whether margin recovers and whether the working-capital build reverses.

The implied second-half NPAT shape from FY25 was NZ$3.4m. To match FY25 NPAT of NZ$6.4m, HY26's NZ$2.9m starting point requires a stronger H2 contribution than the prior pattern, particularly if the tax rate normalises toward 28%.

Open questions

Open questions from HY26

What drove trade debtors to NZ$4.6m from NZ$0.6m, and how much of the NZ$4.4m working-capital build reverses in H2?
Why was the effective tax rate 19.8% versus a 28.1% prior, and is that rate sustainable into H2 and FY27?
What is the explanation for the 8.4% EBITDA margin sitting below the historical 8.8%-12.2% range despite the strongest revenue growth in the window?
How does management justify lifting the interim dividend 15.4% and raising the NPAT payout to 75% when operating cash fell and the cash balance ran down to NZ$0.1m?
Will gross borrowings continue trending down given the working-capital pressure, or has facility usage simply shifted intra-period?

This briefing cannot assess whether the receivables build reflects a change in customer mix, payment terms, or a one-off timing effect, because no segment or commentary detail on the receivables driver was supplied.

Latest result sources

Primary issuer documents used for the FY26 briefing. Document labels are preserved from the publication record; Annolyse does not relabel every financial report as an annual report.

Current period

company filing - FY26

FY26 / results announcement

MFB Annual Report - FY26

FY26 / financial report

MFB Media Release - FY26 Results

FY26 / media release

MFB Results Presentation - FY26

FY26 / results presentation

Prior comparable period

Annual Report FY25

FY25 / financial report

company filing

FY25 / results announcement

Media Release - MFB FY25 Results

FY25 / media release

Results Presentation

FY25 / results presentation

Interim context

company filing

HY26 / results announcement

Interim Report

HY26 / financial report

Interim Results Presentation

HY26 / results presentation

Release context

FY25 Results Announcement Date and Briefing Details

FY25 / commentary

My Food Bag Market Update: FY25 Return to Growth

FY25 / commentary

FY26 Results Announcement Date and Briefing Details

FY26 / commentary

FY26 Interim Results Announcement Date and Briefing Details

HY26 / commentary

Results of 2025 Annual Meeting

HY26 / commentary

Peer context

Other covered Consumer companies

These companies share a broad sector but may not be direct peers. Compare them only where the underlying measures are genuinely comparable.

CMO · FY26

The Colonial Motor Company

11 published result briefings

BGP · HY27

Briscoe Group

10 published result briefings

HLG · HY26

Hallenstein Glasson

10 published result briefings

MCK · HY26

Millennium & Copthorne Hotels New Zealand

10 published result briefings

Compare MFB, CMO, BGP, HLG →Consumer result archive NZX retail comparison

Briefing archive

The full chronological archive contains every published result briefing.

FY26 · Released 21 May 2026

Debtor days hit unprecedented 3.0 as receivables more than tripled

Working capital absorbed NZ$1.5m against a historical mean of NZ$-0.1m, yet net debt still fell NZ$5.1m on stronger free cash flow.

Read briefing

HY26 · Released 20 November 2025

Revenue grew 3.8% but a $4.4m working-capital build drained cash

Trade debtors swelled to $4.6m from $0.6m while a 19.8% tax rate cushioned NPAT against a 12.2% PBT decline.

Read briefing

FY25 · Released 22 May 2025

Net debt cut $4.9m on stronger cash but PBT flat at $8.6m

Operating cash flow rose 35% to $13.2m and full-year dividend tripled to 1.5cps, while revenue and PBT were essentially flat.

Read briefing

HY25 · Released 21 November 2024

PBT up 17.1% but cash quality leans on capex cut and working capital release

Earnings returned to growth on a -1.9% revenue base, but FCF of NZ$6.1m reflects capex falling 92% and an unusual working capital release.

Read briefing

FY24 · Released 23 November 2023

PBT fell 68.2% but NPAT held flat on a zero-tax bridge

Operating earnings collapsed against the company's historical range while a 0.0% effective tax rate masked the deterioration in headline net profit.

Read briefing

HY24 · Released 23 November 2023

NPAT fell 57.6% as net debt/EBITDA jumped to 1.91x, dividend suspended

Revenue down 11.2% and 140bps of gross margin loss have pushed leverage above its historical 0.51x-1.20x range and ended the interim dividend.

Read briefing

Open all 9 result briefings

Get notified when MFB publishes

Get the next My Food Bag Group result briefing and five-year history updates by email.

My Food Bag Group (MFB)

Latest metrics

Valuation

Price and market cap

Profitability multiples

Income and investment-company measures

Price history

Share price

P/E over time

Ask about MFB

Ask about MFB

Sign in to chat

Performance over time

Filing-only history charts

Revenue

Revenue growth

EBITDA-equivalent

EBITDA margin

NPAT

Operating cash flow

More financial metrics

OCF / EBITDA

FCF pre-lease

FCF post-lease

ROE

Net debt

Net debt / EBITDA

DPS

Payout ratio

Debtor days

Inventory days

Operating working-capital movement

HY26 → FY26 Follow-through

What HY26 said to watch

Open questions from HY26

Latest result sources

Current period

Prior comparable period

Interim context

Release context

Other covered Consumer companies

The Colonial Motor Company

Briscoe Group

Hallenstein Glasson

Millennium & Copthorne Hotels New Zealand

Briefing archive

Debtor days hit unprecedented 3.0 as receivables more than tripled

Revenue grew 3.8% but a $4.4m working-capital build drained cash

Net debt cut $4.9m on stronger cash but PBT flat at $8.6m

PBT up 17.1% but cash quality leans on capex cut and working capital release

PBT fell 68.2% but NPAT held flat on a zero-tax bridge

NPAT fell 57.6% as net debt/EBITDA jumped to 1.91x, dividend suspended

Compare this company

Get notified when MFB publishes